Biote Announces Participation in ICR Conference 2022

IRVING, Texas–BioTE Holdings, LLC (“Biote”), a high-growth medical practice-building company operating within the multi-billion dollar hormone optimization space, today announced that its management team will be participating virtually in the ICR Conference 2022.  Terry Weber, Biote’s Chief Executive Officer, will present on Wednesday, January 12, 2022 at 10:00 am EST.

A live webcast of the presentation will be available on the Biote website at https://biote.com/investors. A recording of the presentation will be available on the company website following the event.

Acerca de Biote

Biote operates a high growth, differentiated medical practice-building business within the hormone optimization space. Similar to a franchise model, Biote provides the necessary components to enable practitioners to establish, build, and successfully operate a hormone optimization center to treat patients appropriate for therapy. Biote trains practitioners how to identify and treat early indicators of hormone-related aging conditions.

Media Contact

Chelsea-Lyn Rudder
[email protected]

Investor Contact

Mike Cavanaugh
[email protected]